Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Optical detection represents the next great horizon for cancer imaging. As molecularly targeted therapeutic agents are delivered to the clinic in increasing numbers, there is a parallel opportunity to advance optical imaging techniques. Because of its limited toxicity and potential for real-time information, optical imaging represents an underdeveloped modality in clinical medicine. Optical Imaging of Cancer: Clinical Applications explores the preclinical and clinical data to support the use of these techniques in cancer imaging. Different fluorescent delivery modalities are explored: from…mehr
Optical detection represents the next great horizon for cancer imaging. As molecularly targeted therapeutic agents are delivered to the clinic in increasing numbers, there is a parallel opportunity to advance optical imaging techniques. Because of its limited toxicity and potential for real-time information, optical imaging represents an underdeveloped modality in clinical medicine. Optical Imaging of Cancer: Clinical Applications explores the preclinical and clinical data to support the use of these techniques in cancer imaging.
Different fluorescent delivery modalities are explored: from monoclonal antibodies to viral vector delivery. Indications for use include monitoring therapuetic delivery, early detection, and operative removal techniques in all stages of clinical development. This book represents the best and most clinically relevant techniques currently available.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Part I: Optical Imaging Principles Basic principles Kurt Zinn, University of Alabama at Birmingham Describe principles of optical imaging including chemistry and physics of fluorescence, limitations/advantages of optical imaging compared to metabolic and anatomic imaging. Hardware for imaging John Frangioni, Harvard University Describe hardware adapted for small animal imaging and for clinical applications: endoscopes and operative microscopes. Optical probes GE Healthcare Outline FDA approved and newer optical imaging probes. Include discussion of chemistry and linkage to other proteins. Part II: Cancer Targeting Strategies Introduction to molecular targeting strategies KE Adams, Baylor University Review current techniques to image cancer and the development of techniques to specifically image cancer cells. Tissue auto fluorescence CF Poh, Vancouver, Canada Review use of exploiting differences in tissue autofluorescence to diagnose and treat cancer. Include agents such as 5-aminoleculinic acid. Proteolytic mechanisms O. McIntyre, Vanderbilt University Review mechanisms that require proteolytic processing within the tumor to become active fluorophores. Antigen targeting M Garfinkle, Texas A&M University Review use of cancer selective proteins to localize probes to cancer cells: include toxins, antibodies, and minibodies. Genetically engineered optical imaging TBA Introduction of plasmids, viruses or other genetic material may be used to express fluorescent agents in vivo. This chapter will review multiple vectors and delivery mechanisms of optical imaging cassettes. Part III: Potential Clinical Applications Preclinical investigations: Detection of primary tumors Eben Rosenthal, UAB Preclinical investigations into the use of optical contrast agents for the detection of primary tumors in conventional and orthotopic models will be discussed. Preclinical investigations: Detection of metastatic cancer Y Hama, NIH/NCI Preclinical investigations into the use of optical contrast agents for the detection of metastatic tumors in mouse models will be discussed. Sentinel lymph node imaging P Wunderbaldinger, University of Vienna Use of targeted and non-specific optical contrast agents have been used for the detection of sentinel lymph node detection. These applications and how they differ from other applications will be discussed Neuro-oncologic applications Veiseh M, University of Seattle Because of the unique difficulty of identifying tumor from normal tissue in brain tissue, a separate chapter would be needed. More clinical data is available for this cancer type than any other. Future Directions for Clinical Use of Optical Imaging TBA Discussion of potential clinical applications for optical imaging and an assessment of the potential market.
Part I: Optical Imaging Principles Basic principles Kurt Zinn, University of Alabama at Birmingham Describe principles of optical imaging including chemistry and physics of fluorescence, limitations/advantages of optical imaging compared to metabolic and anatomic imaging. Hardware for imaging John Frangioni, Harvard University Describe hardware adapted for small animal imaging and for clinical applications: endoscopes and operative microscopes. Optical probes GE Healthcare Outline FDA approved and newer optical imaging probes. Include discussion of chemistry and linkage to other proteins. Part II: Cancer Targeting Strategies Introduction to molecular targeting strategies KE Adams, Baylor University Review current techniques to image cancer and the development of techniques to specifically image cancer cells. Tissue auto fluorescence CF Poh, Vancouver, Canada Review use of exploiting differences in tissue autofluorescence to diagnose and treat cancer. Include agents such as 5-aminoleculinic acid. Proteolytic mechanisms O. McIntyre, Vanderbilt University Review mechanisms that require proteolytic processing within the tumor to become active fluorophores. Antigen targeting M Garfinkle, Texas A&M University Review use of cancer selective proteins to localize probes to cancer cells: include toxins, antibodies, and minibodies. Genetically engineered optical imaging TBA Introduction of plasmids, viruses or other genetic material may be used to express fluorescent agents in vivo. This chapter will review multiple vectors and delivery mechanisms of optical imaging cassettes. Part III: Potential Clinical Applications Preclinical investigations: Detection of primary tumors Eben Rosenthal, UAB Preclinical investigations into the use of optical contrast agents for the detection of primary tumors in conventional and orthotopic models will be discussed. Preclinical investigations: Detection of metastatic cancer Y Hama, NIH/NCI Preclinical investigations into the use of optical contrast agents for the detection of metastatic tumors in mouse models will be discussed. Sentinel lymph node imaging P Wunderbaldinger, University of Vienna Use of targeted and non-specific optical contrast agents have been used for the detection of sentinel lymph node detection. These applications and how they differ from other applications will be discussed Neuro-oncologic applications Veiseh M, University of Seattle Because of the unique difficulty of identifying tumor from normal tissue in brain tissue, a separate chapter would be needed. More clinical data is available for this cancer type than any other. Future Directions for Clinical Use of Optical Imaging TBA Discussion of potential clinical applications for optical imaging and an assessment of the potential market.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309